Sanarus Medical

Sanarus Medical, Inc. develops and markets minimally invasive devices for the diagnosis and treatment of breast tumors. It offers Visica treatment system for cryoablation of breast fibroadenomas; Cassi II rotational core biopsy system, an automated hand held breast biopsy device to secure contiguous biopsy samples; and ImarC tissue marker system, a line of breast tissue markers that are visible under imaging modalities.
Pleasanton, US
25 (est)-3%

Sanarus Medical Locations

Pleasanton, US

Sanarus Medical Metrics

Sanarus Medical Summary

Founding Date


Total Funding

$47.9 M

Latest funding size

$15 M

Time since last funding

over 9 years


Sanarus Medical Online Presence

Sanarus Medical News

Sanarus Medical Company Life